Hear Lipinski's "New Rules" for Drug Development

This is a paid advertisement for SmartBrief readers.

The content does not necessarily reflect the view of SmartBrief or its Association partners.

If you are having trouble viewing this message in your e-mail client, please see the web version here

Hear Lipinski's "New Rules" for Drug Development and Hopkins' Lessons for the Drug Hunter! Dear Colleague,   What makes a successful drug? Where have we gone wrong? Will Drug Repurposing help save the industry? Could Phenotypic screening deliver greater success? Biologics — what can we really expect from the future? Target Hopping — should we be exploring fruitful chemical space? Polypharmacology — How to gain multi-target efficacy! The Future Role of Academia and Partnerships in Pharmaceutical Drug Development Can science be truly run as a business, or is this holding back productivity? Hear what two of the most influential drug researchers in the last two decades have to say about the future of drug development in a free webinar and pose your questions directly to Chris Lipinski.   REGISTER FOR THE WEBINAR HERE   Find out more about the webinar here   Event details: Date: October 10th 2012  (October 11th Japan, Asia) Time: 7.00 pm Eastern time, New York / 4.00 pm Pacific Coast time, San Francisco, Los Angeles /  8.00am Tokyo (October 11th), Webinar with Dr. Chris Lipinski and Professor Andrew Hopkins followed by live Q&A  session   Can't attend live? By registering, you will receive an email update on the webinar and a link to the recording! Register your interest here Kind regards, Thomson Reuters Life Sciences Team

About this email: BIO SmartBrief will occasionally send emails from our advertising partners promoting products and services determined to be of interest and relevance to our readers. Each email is carefully considered on a case-by-case basis. If you do not want to receive these emails, you can unsubscribe from them by clicking here. SmartBrief, Inc.® 555 11th ST NW, Suite 600, Washington, DC 20004